These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15955641)

  • 1. Estimated numbers of postmenopausal women treated by hormone therapy in France.
    Gayet-Ageron A; Amamra N; Ringa V; Tainturier V; Berr C; Clavel-Chapelon F; Delcourt C; Delmas PD; Ducimetière P; Schott AM
    Maturitas; 2005; 52(3-4):296-305. PubMed ID: 15955641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation.
    Ringa V; Varnoux N; Piault S; Bréart G
    Fertil Steril; 2005 Jun; 83(6):1771-9. PubMed ID: 15950650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potentially inappropriate prescriptions for the elderly: a study of health insurance reimbursements in Southeastern France].
    Jardin M; Bocquier A; Cortaredona S; Nauleau S; Millon C; Savard-Chambard S; Allaria-Lapierre V; Sciortino V; Bouvenot G; Verger P
    Rev Epidemiol Sante Publique; 2012 Apr; 60(2):121-30. PubMed ID: 22418446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' and clinicians' attitudes after the Women's Health Initiative study.
    Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
    Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of hormonal therapy among Israeli women in the post-WHI era.
    Keinan-Boker L; Dictiar R; Garty N; Green MS
    Maturitas; 2005; 52(3-4):364-73. PubMed ID: 16043316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
    Heitmann C; Greiser E; Dören M
    Menopause; 2005; 12(4):405-11. PubMed ID: 16037755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis management in a Medicaid population after the Women's Health Initiative study.
    Lee E; Wutoh AK; Xue Z; Hillman JJ; Zuckerman IH
    J Womens Health (Larchmt); 2006 Mar; 15(2):155-61. PubMed ID: 16536679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
    Fournier A; Fritel X; Panjo H; Zins M; Ringa V
    Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial.
    Leung KY; Ling M; Tang GW
    Maturitas; 2005; 52(3-4):277-85. PubMed ID: 15950409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts.
    Fournier A; Kernaleguen C; Panjo H; Clavel-Chapelon F; Ringa V
    Menopause; 2011 Feb; 18(2):219-23. PubMed ID: 21052030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
    Hing E; Brett KM
    Obstet Gynecol; 2006 Jul; 108(1):33-40. PubMed ID: 16816053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
    Huang WF; Tsai YW; Hsiao FY; Liu WC
    BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
    Salpeter S
    Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.